Omnipod
Payments companies reported to CMS as associated with Omnipod. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Omnipod, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Omnipod
These are the largest totals companies reported as associated with Omnipod. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anita Swamy | Chicago, IL | Pediatric Endocrinology | $262,590.39 |
| Wayne Frederick | Washington, DC | Surgical Oncology | $237,732.00 |
| Luciana Borio | Baltimore, MD | Infectious Disease | $209,141.31 |
| Marina Charitou | East Setauket, NY | Endocrinology, Diabetes & Metabolism | $150,220.89 |
| Eden Miller | Bend, OR | Family Medicine | $147,348.28 |
| Martin Sarkar | Frederick, MD | Endocrinology, Diabetes & Metabolism | $147,256.60 |
| Ania Janicka | Hudson, FL | Endocrinology, Diabetes & Metabolism | $137,855.79 |
| Pablo Mora | Dallas, TX | Endocrinology, Diabetes & Metabolism | $134,108.06 |
| Thomas Oconnell | Burlington, NC | Endocrinology, Diabetes & Metabolism | $121,747.12 |
| Jori Matushek | Westfield, IN | Pediatrics (Nurse Practitioner) | $111,935.67 |
Prescribed Omnipod?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.